Cannabis Report

Cannabis Report: Canopy Growth
Thinks Ahead While U.S.
Cannabis Research Falls Behind

Cannabis Report: Canopy Growth
Thinks Ahead While U.S.
Cannabis Research Falls Behind

IPO fever is here again. Pinterest and Zoom both went public last week and promptly grabbed all the headlines. But in the midst of the IPO frenzy, an American cannabis stock quietly made its debut on the Nasdaq.

Meanwhile, Canopy Growth, one of our portfolio holdings, has made another smart move. This time it’s making a big bet on the U.S.

Medical marijuana can treat a laundry list of conditions. Epilepsy, autism, and multiple sclerosis are just a few.

But the U.S. is failing miserably to harness this potential. And listening to the people that could have been helped by medical marijuana makes you wonder why…

Top Posts on Early Investing